Symptoms, Warning Signs, and Emergencies in DADA2
At a Glance
DADA2 can cause inflammation in small blood vessels, leading to fevers, skin changes, and stroke. Sudden weakness, facial drooping, speech or vision changes, severe headache, seizures, or confusion require an immediate call to emergency services, even if symptoms improve.
Living with DADA2 means learning to distinguish between the routine symptoms of chronic inflammation and the “red flag” signs of a medical emergency. While the disease can affect many parts of the body, the most critical risks involve the blood vessels and the nervous system [1][2].
Routine Inflammatory Symptoms
Many people with DADA2 experience ongoing symptoms that, while distressing, are typically managed through regular specialist care. It is important to note that the exact percentages of patients experiencing these symptoms vary substantially depending on the cohort, age, and phenotype studied:
- Recurrent Fevers: A large portion of patients (roughly half in some studies) experience fevers that come and go without a clear infection [3]. These are part of the body’s overactive inflammatory response [4].
- Skin Changes: Skin manifestations are very common [3]. The most classic is livedo racemosa, a purple, lace-like pattern on the skin that looks like a net [5]. Unlike simple livedo reticularis, which often disappears when the skin is warmed, livedo racemosa is often persistent and covers larger, irregular areas [6].
- Aches and Pains: Many patients experience joint pain or swelling, and some report significant muscle pain [3].
- Fatigue: A deep, persistent tiredness is reported by many patients [5].
Understanding Stroke in DADA2
The most serious complication for many with DADA2 is stroke. Because the disease causes inflammation in small blood vessels, it can lead to lacunar infarcts (small areas of damage) in various parts of the brain [2][7]. Neurological events can start in childhood and affect a significant portion of patients [1][3].
There are two main types of stroke seen in DADA2:
- Ischemic Stroke: This happens when a blood vessel is blocked, cutting off oxygen to the brain. This is the most common type in DADA2 [2].
- Hemorrhagic Stroke: This happens when a weakened blood vessel leaks or bursts [8][7].
EMERGENCY RED FLAGS: STROKE
Seek immediate emergency medical care (call 911 or your local emergency number) if you or your child experience any sudden neurological changes. Do NOT drive the patient to the hospital yourself—call for an ambulance.
- F - Face: One side of the face droops or is numb. When the person smiles, the smile is uneven [9].
- A - Arm: One arm (or leg) is weak or numb. If the person tries to raise both arms, one arm drifts downward [9].
- S - Speech: Speech is slurred, or the person is unable to speak or hard to understand [9].
- T - Time: Note the “last known well” time and call emergency services immediately.
Other Neurological Red Flags:
Strokes in DADA2 can affect areas like the brainstem and deep brain structures, but lacunar injury can happen in many different parts of the brain. You must also seek emergency care for any sudden changes, even if they resolve, including:
- Sudden loss of balance, coordination, trouble walking, or severe dizziness [2].
- Double vision, sudden loss of vision, or abnormal eye movements [1].
- Sudden difficulty swallowing, a change in voice, or speech changes [10].
- Sudden, severe, or unusual headache [1].
- A new seizure, sudden confusion, or behavior changes [2].
A Note on Blood Thinners and Aspirin
Because DADA2 can involve both ischemic strokes (clots) and hemorrhagic strokes (bleeds), you should not self-medicate with aspirin or blood thinners if you suspect a stroke. Call emergency services immediately. Let the emergency or hematology team decide on the use of antiplatelet or anticoagulant medications after they have performed brain imaging and reviewed your individual bleeding risk. Do not independently stop a blood thinner that was previously prescribed to you by a specialist without their direct guidance [8][11].
Other Serious Signs and Emergencies
Beyond stroke, other symptoms require prompt medical attention because they may indicate organ damage or severe inflammation.
Seek Emergency Care For:
- Bowel Ischemia/Major Bleeding: Severe abdominal pain, vomiting blood, fainting, or black/bloody stools [4][12].
- Threatened Tissue: If fingers or toes become suddenly blue, cold, or intensely painful [13].
- Hypertensive Emergency: Very high blood pressure accompanied by symptoms like severe headache or chest pain [14][15].
Call Your Specialist Same-Day For:
- Unusual Bleeding: Minor but unusual bruising or nosebleeds [16].
- Infection Risks: Fever while taking a biologic medication (like a TNF inhibitor) or when you are known to have low white blood cells. This could be a sign of a serious infection rather than just a DADA2 flare. Work with your doctor to establish a clear temperature threshold and action plan for fevers.
Common questions in this guide
What symptoms are common in people with DADA2?
Which symptoms could mean a stroke in someone with DADA2?
Should I take aspirin if I think someone with DADA2 is having a stroke?
What other DADA2 symptoms need emergency care?
When should a fever in DADA2 be treated as urgent?
Get notified when new evidence is published on Deficiency of adenosine deaminase 2.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency.
Dzhus M, Ehlers L, Wouters M, et al.
Journal of clinical immunology 2023; (43(8)):1916-1926 doi:10.1007/s10875-023-01555-y.
PMID: 37548813 - 2
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study.
Verschoof MA, van Meenen LCC, Andriessen MVE, et al.
European journal of neurology 2024; (31(1)):e16043 doi:10.1111/ene.16043.
PMID: 37584090 - 3
A wide spectrum of phenotype of deficiency of deaminase 2 (DADA2): a systematic literature review.
Maccora I, Maniscalco V, Campani S, et al.
Orphanet journal of rare diseases 2023; (18(1)):117 doi:10.1186/s13023-023-02721-6.
PMID: 37179309 - 4
ADA2 deficiency (DADA2) misdiagnosed as systemic onset juvenile idiopathic arthritis in a child carrying a novel compound heterozygous ADA2 mutation: a case report.
Yin J, Fan X, Ma J, et al.
Translational pediatrics 2023; (12(1)):97-103 doi:10.21037/tp-22-261.
PMID: 36798931 - 5
Pediatric-Onset Polyarteritis Nodosa and Deficiency of Adenosine Deaminase 2: Clinical Overlap and Divergence.
Atamyildiz Uçar S, Tunce E, Türkmen Ş, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2025; (31(8)):299-305 doi:10.1097/RHU.0000000000002270.
PMID: 40815801 - 6
Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.
Lee PY
Frontiers in pediatrics 2018; (6()):282 doi:10.3389/fped.2018.00282.
PMID: 30406060 - 7
Decoding neurovascular signatures: advanced imaging insights in DADA2-Related Cerebral Microangiopathy.
Zhou Y, Shen M, Jiang N, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (47(1)):18.
PMID: 41413740 - 8
TNF-Blockade for Primary Stroke Prevention in Adenosine Deaminase 2 Deficiency: A Case Series.
Soldatos A, Toro C, Hoffmann P, et al.
Neurology(R) neuroimmunology & neuroinflammation 2023; (10(3)) doi:10.1212/NXI.0000000000200073.
PMID: 36941081 - 9
Two Unrelated Iranian Patients with Adenosine Deaminase 2 Deficiency: A Case Report and Review of Treatment.
Karimzade P, Eghbali A, Keramatipour M, et al.
Case reports in immunology 2024; (2024()):4380689 doi:10.1155/2024/4380689.
PMID: 39161369 - 10
Vasculitic peripheral neuropathy in deficiency of adenosine deaminase 2.
Carneiro DR, Rebelo O, Matos A, et al.
Neuromuscular disorders : NMD 2021; (31(9)):891-895 doi:10.1016/j.nmd.2021.05.001.
PMID: 34210540 - 11
[Multiple facets of ADA2 deficiency: Vasculitis, auto-inflammatory disease and immunodeficiency: A literature review of 135 cases from literature].
Fayand A, Sarrabay G, Belot A, et al.
La Revue de medecine interne 2018; (39(4)):297-306 doi:10.1016/j.revmed.2017.11.006.
PMID: 29273180 - 12
Vasculitis associated with adenosine deaminase 2 deficiency: at the crossroads between Behçet's disease and autoinflammation. A viewpoint.
Colangelo A, Tromby F, Cafaro G, et al.
Reumatismo 2023; (75(3)) doi:10.4081/reumatismo.2023.1578.
PMID: 37721348 - 13
A Case of Deficiency of Adenosine Deaminase 2: 28 years of Diagnostic Challenges.
Pardinhas C, Santo G, Escada L, et al.
Case reports in nephrology and dialysis 2021; (11(3)):340-347 doi:10.1159/000517141.
PMID: 35083289 - 14
Clinical spectrum of and outcomes for Indian children with deficiency of adenosine deaminase 2 (DADA2): a multicentric study.
Kumar S, Chugh A, Kumar SC, et al.
Rheumatology (Oxford, England) 2025; (64(4)):2179-2184 doi:10.1093/rheumatology/keae489.
PMID: 39259214 - 15
Early onset is an indication of the severity of DADA2 disease.
Zhao X, Zhang J, Li C, et al.
Rheumatology (Oxford, England) 2023; (62(2)):969-976 doi:10.1093/rheumatology/keac233.
PMID: 35471231 - 16
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.
Bulté D, Barzaghi F, Mesa-Nuñez C, et al.
The Journal of allergy and clinical immunology 2025; (155(2)):616-627.e8 doi:10.1016/j.jaci.2024.09.007.
PMID: 39284370
This page is for informational purposes only and does not constitute medical advice. It cannot replace emergency evaluation; ask your DADA2 specialist for a personalized fever, medication, and emergency plan.